Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BROLUCIZUMAB vs BUCILLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BROLUCIZUMAB vs BUCILLAMINE: Safety Overview

Metric BROLUCIZUMAB BUCILLAMINE
Total FAERS Reports 682 163
Deaths Reported 41 20
Death Rate 6.0% 12.3%
Hospitalizations 105 76
Average Patient Age 69.5 yrs 67.0 yrs
% Female Patients 57.1% 66.3%
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route INTRAVITREAL N/A